0001209191-20-035117.txt : 20200608 0001209191-20-035117.hdr.sgml : 20200608 20200608190634 ACCESSION NUMBER: 0001209191-20-035117 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200605 FILED AS OF DATE: 20200608 DATE AS OF CHANGE: 20200608 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pasternak Richard C CENTRAL INDEX KEY: 0001792810 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38899 FILM NUMBER: 20950484 MAIL ADDRESS: STREET 1: C/O MILESTONE PHARMACEUTICALS INC. STREET 2: 1111 DR. FREDERIK-PHILIPS BLVD, STE 420 CITY: MONTREAL STATE: A8 ZIP: H4M2X6 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Milestone Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001408443 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1111 DR. FREDERIK-PHILIPS BLVD STREET 2: SUITE 420 CITY: MONTREAL STATE: A8 ZIP: H4M 2X6 BUSINESS PHONE: (514) 336-0444 MAIL ADDRESS: STREET 1: 1111 DR. FREDERIK-PHILIPS BLVD STREET 2: SUITE 420 CITY: MONTREAL STATE: A8 ZIP: H4M 2X6 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-05 0 0001408443 Milestone Pharmaceuticals Inc. MIST 0001792810 Pasternak Richard C C/O MILESTONE PHARMACEUTICALS INC. 1111 DR. FREDERIK-PHILIPS BLVD, STE 420 MONTREAL A8 H4M 2X6 QUEBEC, CANADA 1 0 0 0 Stock Option (right to buy) 3.74 2020-06-05 4 A 0 15000 0.00 A 2030-06-05 Common Shares 15000 15000 D The shares subject to this option shall vest in equal monthly installments over the 12 months commencing July 5, 2020, provided that the shares subject to this option shall vest in full on the date of Issuer's 2021 annual meeting of shareholders, subject to recipient continuing to provide service to the Issuer through such vesting date. /s/ Eric Popp, Attorney-in-Fact 2020-06-08